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Measurement of quality of life is especially pertinent in chronic diseases that have periods of activity and remission and for which there is no cure, as is the case in IBD. 5 Therefore, the quality of life should be taken into account when evaluating the results of different treatments in subjects with this type of disease, 6 and restoring previous quality of life should be one of the therapeutic objectives. 7 Disease activity has been identified as one of the determining factors in the reduction of health-related quality of life (HRQOL) in IBD. 8 However, in addition to the aspects specifically related to the disease itself, psychological factors can also influence a patient's perception of health.
The presence of a chronic medical condition is often associated with a high level of anxiety and mood disorders when compared with the general population. [9] [10] [11] Both psychological variables seem to have an important impact on the clinical course of the disease 12, 13 and HRQOL. [13] [14] [15] Stress, and the way individuals try to manage it, also seems to act as a moderator in HRQOL in patients with IBD. 5, 16 Nevertheless, despite there being a significant number of studies that have focused on HRQOL in IBD, only a small number of them have considered all of these psychological variables together, 17, 18 making it very difficult to identify the differential contribution of each of these variables in the different dimensions that make up HRQOL in patients with IBD.
The purpose of this study was to analyze the existing associations between psychological variables (anxiety and depression symptoms, stress and coping strategies) and HRQOL in patients with IBD, controlling for the effect of the relevant clinical and sociodemographic variables.
METHODS

Design, Population, and Sample
A cross-sectional, prospective study with consecutive patient recruitment was designed. The study population consisted of consecutive patients with IBD (CD and UC) who attended the IBD Unit at the University Hospital of Santiago de Compostela, Spain, from January 2009 to June 2010.
The inclusion criteria were diagnosis of CD or UC based on conventional clinical, endoscopic, radiographic, and histological criteria and age being 18 years or more. The exclusion criteria were inability to adequately complete the questionnaires due to cognitive impairment, or unwillingness to participate in the study. The study was approved by the local ethics committee (2008/414).
Data Collection
A physician specialized in IBD collected clinical data and explained the study objectives, including the expected contribution of the patient in the study. Patients were then seen by a specialized psychologist who recorded sociodemographic data, obtained informed consent, and distributed study questionnaires together with instructions for its proper completion.
The Short Form 36 Health Survey (SF-36) is a generic scale that provides a health status profile and applies to both patients and the general population. The SF-36 consists of 35 questions (items) that are scored to assess both positive and negative health states. Scales range from 0 to 100, with 0 being the worst score and 100 the best score. The SF-36 includes Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, and Mental Health. There is also an additional item that is not part of any specific dimension that measures change in health over time. 19 The Inflammatory Bowel Disease Questionnaire (IBDQ) is an instrument specifically designed to assess HRQOL in patients with UC and CD. The IBDQ version of Love et al 20 was used. This is a self-administered questionnaire consisting of 36 items, distributed into 5 dimensions (Bowel Symptoms, Systemic Symptoms, Functional Impairment, Social Impairment, and Emotional Function) scored from 1 to 7 using a Likert scale (corresponding to the worst and best functioning levels, respectively). The total score ranges from 36 to 252, with higher scores reflecting a better HRQOL.
Anxious and depressive symptoms were assessed using the validated Spanish version of the Hospital Anxiety and Depression Scale (HADS). 21 This instrument consists of 14 items with subscales for anxiety (7 items) and depression (7 items) graded for severity. The total score in each subscale ranges from 0 and 21, with a score greater than 11 suggesting a clinically significant impairment.
For the evaluation of stress, we have used the perceived stress scale (PSS). 22 This scale is a self-administered instrument that evaluates the level of perceived stress in the previous month. It consists of 14 items with a 5-point response format (0 ¼ never, 1 ¼ almost never, 2 ¼ sometimes, 3 ¼ often, and 4 ¼ very often). The direct score obtained indicates that a higher score corresponds to a higher level of perceived stress (range, 0-56).
Finally, coping strategies were evaluated using the COPE. 23 It consists of a total of 60 items, each of which is scored between 1 and 4 (a higher value indicates higher frequency of use). It provides information on 3 types of coping: coping with the problem, coping with emotions, and escape-avoidance. 24, 25 For all the instruments, versions adapted to the Spanish population were used.
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Independent Variables
The following sociodemographic and clinical data were collected from all patients: age; sex; marital status; educational level; smoking habits; age at IBD diagnosis; time since diagnosis; type of disease (CD or UC); disease location (ileal, colonic, or ileocolonic) and behavior (inflammatory, stenosing, or fistulizing) for CD and location for UC (E1: proctitis, E2: left-sided colitis, or E3: pancolitis) according to the Montreal classification; type of treatment; extraintestinal manifestations; perianal disease; presence of a relapse or being in remission (defining remission in CD as a Harvey and Bradshaw index #4 and in UC as a Mayo index #2); number of relapses in the previous year; and hospital admissions and emergency department visits related to the disease during the previous year.
For logistic regression analysis, continuous variables were categorized as follows: subject age (in quartiles) (18-31; 32-40; 41-52; 53-85); age at diagnosis (8-21; 22-35; 36-50; .50), years since diagnosis (0; 1; 2; .2), and relapses in past year (0; 1; $2).
Regarding the scores on the questionnaires, the score from the PSS questionnaire is categorized into tertiles (0-18; 19-26; and 27-56). Coping was categorized based on the tenth percentile for each factor, the cutoff used was 1.33 for coping with the problem, 1.0 for coping with emotions, and 1.25 for escapeavoidance, respectively.
Dependent Variables
Dependent variables included the quality of life dimensions assessed using both the SF-36 (Physical Functioning, RolePhysical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional and Mental Health) and the IBDQ (Bowel Symptoms, Systemic Symptoms, Functional Impairment, Social Impairment, Emotional Function, and total score).
Statistical Analyses
Sociodemographic and clinical characteristics of patients are displayed as frequencies (proportions) for categorical variables and as means for quantitative variables. Questionnaire scores are also provided as means. For HADS, the proportions of patients considered with clinically significant anxiety and/or depression are given.
Multivariate logistic regression was used to identify the contribution of sociodemographic, clinical, and psychological variables in the different SF-36 and IBDQ dimensions factors associated with lower than normal values. In the case of the SF-36 questionnaire, the scores were standardized using normative data in the Spanish population. 31 Afterward, the scores were dichotomized based on whether or not they were above or below the fifth percentile of the reference population. Dimensions with values under the fifth percentile were considered to be affected. In the case of the IBDQ, we use 209 as a cutoff value as established previously by Huamán et al. 32 All potential risk factors were considered as potential confounding factors in the analysis. Covariables were introduced in the final model if they were significant or if their exclusion changed the coefficients of other covariates by more than 10%.
RESULTS
Of the 875 patients who sought consultation and met the inclusion criteria, 793 agreed to participate, yielding a participation rate of 91.3%. At the time of evaluation, 314 (39.3%) were in an exacerbation. Of the total, 323 (40.7%) were patients with CD and 470 (59.3%) with UC. The demographic and clinical characteristics of the patients are shown in Table 1 Table 2) .
The description of the HRQOL for IBD patients compared with the reference population values shows that the HRQOL of patients with IBD is below the reference population values except on the Physical Function, Social Function, and Emotional Function Scales (Fig. 1 ). There were no differences in the measurements based on disease type (CD or UC) or any other characteristic ( Table 2) .
The coping strategy most often used by patients with IBD has been coping focused on emotions (¼ 2.65; 95% CI ¼ 2.61-2.69). The mean PSS score was 23.54 (95% CI: 22.86-24.23). Of note, 10.5% of patients had a score greater than 11 for anxiety and 20.1% for depression, which indicates a clinical suspicion of anxiety and depression, respectively 20 ( Table 2) . Table 3 shows the percentage of subjects with a poorer HRQOL in the different dimensions of the SF-36 and IBDQ questionnaires. Table 4 shows the explicatory variable from the IBDQ and each of the generic dimensions of quality of life analyzed using the SF-36.
DISCUSSION
We have identified the significant impact of IBD on HRQOL of patients in this large cohort, and we have described the contribution of psychological variables (stress and anxiety and depressive symptoms) to its deterioration. The results of this study show how psychological variables, particularly stress, anxiety, and depressive symptoms are relevant determinants of HRQOL in this patient group. The data obtained on the quality of life dimension from the SF-36 questionnaire indicate that the HRQOL of patients with IBD, when compared with normative data from the general population in Spain, is affected in all dimensions of the questionnaire with the exception of Physical Function. The most pronounced differences have been General Health, coinciding with Bernklev et al 33 in a study on a Norwegian population. On the specific IBDQ scales, lower scores are seen on the Systemic Symptoms scale, with the social dimension having some of the highest scores. This affectation pattern coincides with that reported previously in the Spanish population. 3 The impact of IBD on the evaluated HRQOL dimensions seems to be explained not only by the physical status but also by the psychological status of the patients even after taking into account such relevant variables as the presence of disease activity. Stress and anxiety and depressive symptoms have been shown to be important predictors of HRQOL in all the dimensions evaluated.
Without a doubt, stress represents an important risk factor for the deterioration of HRQOL. Patients often indicate highly stressful events to be responsible for the onset of the disease or an exacerbation. [34] [35] [36] However, many of these studies have important methodological limitations that do not allow conclusive statements to be made. 5 One of the groups that have published more information about the relation between stress and relapses is the group from Rome; in which, 62 UC patients demonstrated that patients with higher levels of stress had a higher risk of relapse. 37 Studies performed by the group from Quebec in more than 200 patients with IBD showed a clear relation between perceived stress and the activity of the disease. 38 Despite not being able to demonstrate the causality of stress on outbreaks, the findings from a study performed by Bernstein et al 39 support the association between perceived stress and an increase in symptoms compatible with IBD. Therefore, our data show that stress may indirectly affect exacerbation of disease activity in addition to the direct negative effect on quality of life. 5 Consequently, it seems to be a very important variable in the management of these patients.
As we expected, anxiety and depression constitute a risk factor for those scales related to emotional well-being (RoleEmotional and Mental Health), but it is also worth keeping in mind that symptoms of anxiety and depression, either independently or together, contribute to explaining the perception of physical status (Physical Function, Role-Physical, Vitality) and even general health, making them important risk factors for a deterioration in HRQOL. Anxiety-depression comorbidity has a considerable prevalence in our sample (10.5% for anxiety and 20.1% for depression), though it is slightly lower than that reported previously, given that anxiety and/or depression prevalence levels between 29%-35% have been found during remission, 13, 40 as has 80% and 60% for depression during periods of exacerbation. 41 Nevertheless, it should be pointed out that the HADS questionnaire is not an instrument for making diagnosis, it only can measure states of anxiety and depression.
This lack of coincidence may be due to the fact that in some previous studies, different instruments than those used by us were used, 13, 40 and this can be a bias against the interpretation of the results. 42 In the same way, we can observe the strong impact of anxiety and depressive symptoms on HRQOL. In addition to the importance that these variables seem to have in the well-being of these patients, it is known that a great amount of the disability and functional affectation that occurs in chronic health problems is associated with anxiety and depression more than the disease characteristics themselves. 12, 43 Therefore, evaluating these psychological symptoms seems to be valid both in the evaluation and the intervention in HRQOL 15 This is nothing new in IBD given that the need for interventions on the psychological impact of the disease has been recognized, because it has been in other pathologies such as coronary artery disease and diabetes. 44, 45 Contrary to what was expected, no association was found between the form of coping with stress and HRQOL, unlike what was seen in previous studies on patients with IBD. 46 It is difficult to find an explanation for these results. In fact, these same results were obtained in previous studies where in addition to coping, they also evaluated the presence of psychological comorbidity in patients on peritoneal dialysis 47 and patients with IBD. 16 Regarding the importance of sociodemographic and clinical variables, the results once again point out the role of age, 48 extraintestinal manifestations, the presence of an exacerbation, and the number of previous recurrences on HRQOL. 3, 8 There seems to be a more limited effect, affecting a lower number of scales, because of age at diagnosis, years of disease progression, type of disease (diagnosis of CD), type of treatment (use of mesalazine, corticosteroids, immunosuppressants, or biological agents versus untreated subjects), tobacco use, and hospitalizations, though these have also been reported as potential risk factors for the deterioration of HRQOL in these patients. 5, 8, [49] [50] [51] The strength of this study rests on the large number of patients who have been studied and the use of validated questionnaires with an adequate number of psychometric properties for evaluating psychological variables and the quality of life. In addition, all the measurements were performed at the same center and by the same personnel (specialist physician and trained psychologist).
The results obtained should be interpreted while keeping a series of limitations in mind. The primary limitation is due to the cross-sectional design of our study. We can only establish relationships between variables. It is not possible to define the contributions of causality.
In conclusion, this study indicates that stress and anxiety and depressive symptoms are significant predictors of HRQOL in patients with IBD. Therefore, those patients who have these psychological characteristics may benefit from incorporation in their medical treatment of psychological interventions directed at acting on these potentially modifiable factors. 
